Holen Sie sich die Stockscreener-App
28.90
1.26%
0.36
Handel nachbörslich:
28.90
Harmony Biosciences Holdings Inc Aktie (HRMY) Neueste Nachrichten
US applications for jobless aid rose modestly to 212,000 last week as layoffs remain at historically healthy levels - Bitget
Safe Bulkers, Inc. to Participate in the Dry Bulk Shipping Panel at the DNB Carnegie Energy & Shipping Conference in Oslo - Bitget
Truist Securities Downgrades Harmony Biosciences Holdings, Inc. (HRMY) to Hold After Patent Trial Developments - Yahoo! Finance Canada
Harmony Biosciences (HRMY) Is Down 20.1% After Reaffirming WAKIX Outlook and Winning Pediatric Approval - simplywall.st
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
UBS Group Lowers Harmony Biosciences (NASDAQ:HRMY) Price Target to $36.00 - MarketBeat
Harmony Biosciences (HRMY): UBS Lowers Price Target to $36 | HRM - GuruFocus
HC Wainwright Reiterates Buy Rating for HRMY with $55 Target | H - GuruFocus
Harmony Biosciences' (HRMY) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
BEAM's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y - Finviz
RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up - Finviz
Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y - Finviz
Corcept's Q4 Earnings and Revenues Fall Short of Estimates - Finviz
Analysts Offer Insights on Healthcare Companies: ProQR (PRQR), Immunic (IMUX) and Harmony Biosciences Holdings (HRMY) - The Globe and Mail
UBS cuts Harmony Biosciences stock price target on earlier Wakix generic entry - Investing.com
Harmony Biosciences Holdings, Inc. Experiences Revision in Its Stock Evaluation Amid Market Volatility - Markets Mojo
Bank of America Lowers Harmony Biosciences (NASDAQ:HRMY) Price Target to $28.00 - MarketBeat
Needham & Company LLC Issues Pessimistic Forecast for Harmony Biosciences (NASDAQ:HRMY) Stock Price - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q4 2025 Earnings Call Transcript - Insider Monkey
Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $36 at UBS - StreetInsider
CAVA Group To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga
B of A Securities Lowers Harmony Biosciences (HRMY) Price Target to $28 | HRMY Stock News - GuruFocus
Decoding Harmony Biosciences Holdings Inc (HRMY): A Strategic SWOT Insight - GuruFocus
Harmony Biosciences Holdings, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Harmony Biosciences Holdings Inc (HRMY) Q4 2025 Earnings Call Hi - GuruFocus
Harmony Biosciences (HRMY) Reports Strong Q4 2025 Results, Eyes Blockbuster Revenue - GuruFocus
Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $28 at BofA Securities - StreetInsider
Truist reiterates Hold on Harmony Biosciences stock, sets $25 target By Investing.com - Investing.com Canada
Truist reiterates Hold on Harmony Biosciences stock, sets $25 target - Investing.com UK
Truist SecuritiesReinstates $25 target on Harmony Biosciences Holdings Inc. (HRMY) - StreetInsider
Harmony Biosciences Holdings (HRMY) Stock Analysis: Positioned for a 70% Upside in Biotech Sector - DirectorsTalk Interviews
Harmony Biosciences Hits Day Low at $26.03 Amid Price Pressure - Markets Mojo
Harmony Biosciences Holdings, Inc. Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo
Harmony Biosciences Q4 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: Harmony Bio misses Q4 2025 EPS estimates - Investing.com UK
Earnings call transcript: Harmony Bio misses Q4 2025 EPS estimates By Investing.com - Investing.com India
Zacks.com highlights 4 value stocks amid AI-driven market volatility - National Today
HRMY: Record revenue, strong WAKIX growth, and pipeline advances set up blockbuster 2026 - TradingView
Harmony Biosciences Holdings, Inc Reveals Retreat In Q4 Profit - Nasdaq
Harmony Biosciences Holdings, Inc. (HRMY) Q4 Earnings Miss Estimates - Yahoo Finance
Harmony Biosciences Q4 Adjusted Net Income Drops, Net Product Revenue Rises; Full-Year 2026 Wakix Revenue Guidance Reiterated - marketscreener.com
Harmony Biosciences Reports $868.5 Million Revenue for 2025, Guidance for 2026 Exceeds $1 Billion - Intellectia AI
Harmony Biosciences Holdings, Inc. SEC 10-K Report - TradingView
Harmony Biosciences misses Q4 earnings despite revenue beat By Investing.com - Investing.com India
Harmony Biosciences misses Q4 earnings despite revenue beat - Investing.com
Earnings Flash (HRMY) Harmony Biosciences Holdings, Inc. Reports Q4 Revenue $243.8M, vs. FactSet Est of $240.3M - marketscreener.com
Harmony Biosciences Hldgs Earnings Review: Q4 Summary - Benzinga
Narcolepsy drug WAKIX nears $1B blockbuster year for Harmony Biosciences - Stock Titan
How The Story On Harmony Biosciences (HRMY) Is Shifting With Wakix Legal And Generic Risks - Yahoo Finance
Harmony Biosciences Shares Fall After Deutsche Bank Downgrade - marketscreener.com
Harmony Biosciences (HRMY) Faces Downgrades Amid Legal Concerns - GuruFocus
Harmony Biosciences tumbles following Deutsche Bank, Truist downgrades - Seeking Alpha
FDA Accepts Roche's NDA Seeking Approval for Breast Cancer Drug - Finviz
Amicus' Q4 Earnings Miss, Higher Product Sales Drive Y/Y Revenues - TradingView
Harmony Biosciences Stock Slides on Wakix Patent Fears - TipRanks
Harmony Biosciences (NASDAQ:HRMY) Stock Rating Lowered by Truist Financial - MarketBeat
Deutsche Bank cuts Harmony Biosciences stock rating on patent risk By Investing.com - Investing.com India
2.90%
2.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):